Abstract Changes in the glycosylation process appear early in carcinogenesis and evolve
with the growth and spread of cancer. The correlation of the characteristic glycosylation …

Gastrointestinal (GI) cancer is the most common group of malignancies and many of its types
are among the most deadly. Various glycoconjugates have been used in clinical practice as …

There is a long research history of studying the function of glycosylation in relation to the
development and progression of different types of cancer. The technological advances of the …

Despite significant worldwide investment in research, cancer remains one of the most
common cause of death in the world. Early detection and reliable diagnosis are the keys to …

Glycosylation is among the most important post-translational modifications for proteins and
is of intrinsic complex character compared with DNAs and naked proteins. Indeed, over 50 …

Glycoconjugates constitute a major class of biomolecules which include glycoproteins,
glycosphingolipids and proteoglycans. Glycans are involved in several physiological and …

Cancer early detection and treatment response prediction continue to pose significant
challenges. Cancer liquid biopsies focusing on detecting circulating tumor cells (CTCs) and …

BACKGROUND: Non-invasive biomarkers, such as those from serum, are ideal for disease
prognosis, staging and monitoring. In the past decade, our understanding of the importance …

The lack of specific and sensitive tumour markers for early detection of cancer is driving a
search for new approaches that could identify biomarkers. Markers are needed to alert …

The change of cellular glycosylation is one of the key events in malignant transformation and
neoplastic progression, and tumor‐related glycosylation alterations are promising targets in …